SECreport

Form 4 PROVECTUS BIOPHARMACEUTI For: Feb 02 Filed by: Raines Heather

PROVECTUS BIOPHARMS  (PVCT) 
NASDAQ:AMEX Investor Relations: provectusbio.com/financial-overview